论文信息 - 540P Safety and efficacy from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating a CD8α co-receptor and an affinity optimized TCR targeting MAGE-A4 - 字舞流文

540P Safety and efficacy from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating a CD8α co-receptor and an affinity optimized TCR targeting MAGE-A4

D. Lawrence | M. Butler | V. Boni | J. Zugazagoitia | G. Blumenschein | T. Johanns | J. Charlson | A. Asch | M. B. Blum Murphy | P. Kebriaei | J. Clarke | M. D. de Miguel | E. Norry | E. Calvo | D. Hong | H. Danesi | V. M. García | Q. Lin